Embryonic striatal neurons transplanted into marmoset brains become integrated into host tissue and induce functional recovery in a primate model of Huntington's disease (pages 727–729).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kendall, A.L. et al. Functional integration of striatal allografts in a primate model of Huntington's disease. Nature Med. 4, 727–729 (1998).
Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is unstable in Huntington's disease chromosomes. Cell 72, 971–983 (1993).
Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4, 387–392 (1993).
Andrew, S.E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4, 398–403 (1993).
MacDonald, M.E. & Gusella, J.F. Huntington's disease: Translating a CAG repeat into a pathogenic mechanism. Curr. Opin. Neurobiol. 6, 638–643 (1996).
Strong, T.V. et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genet. 5, 259–265 (1993).
Ferrante, R.J. et al. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 9, 3052–3063 (1997).
Mangiarini, L. et al. Exon 1 of the Huntington's disease gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).
Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548 (1997).
DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997).
Björklund, A. & Stenevi, U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177, 555–560 (1979).
Lindvall, O. et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 247, 574–577 (1990).
Dunnett, S.B. & Svendsen, C.N. Huntington's disease: animal models and transplantation repair. Curr. Opin. Neurobiol. 3, 790–796 (1993).
Nakao, N., Grasbon-Frodl, E.M., Widner, H. & Brundin, P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience 74, 959–970 (1996)
Kopyov, O.V., Jacques, S., Lieberman, A., Duma, C.M. & Eagle, K.S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 149, 97–108 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horellou, P., Mallet, J. Neuronal grafts for Huntington's disease. Nat Med 4, 669–670 (1998). https://doi.org/10.1038/nm0698-669
Issue Date:
DOI: https://doi.org/10.1038/nm0698-669
